Page last updated: 2024-08-16

1,2,5,8-tetrahydroxy anthraquinone and dichlororibofuranosylbenzimidazole

1,2,5,8-tetrahydroxy anthraquinone has been researched along with dichlororibofuranosylbenzimidazole in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balanda, AO; Bdzhola, VG; Briukhovetska, NV; Golub, AG; Gryshchenko, AA; Kotey, IM; Kukharenko, OP; Ostrynska, OV; Yarmoluk, SM1

Other Studies

1 other study(ies) available for 1,2,5,8-tetrahydroxy anthraquinone and dichlororibofuranosylbenzimidazole

ArticleYear
Design and synthesis of novel protein kinase CK2 inhibitors on the base of 4-aminothieno[2,3-d]pyrimidines.
    European journal of medicinal chemistry, 2016, Jun-10, Volume: 115

    Topics: Casein Kinase II; Dose-Response Relationship, Drug; Drug Design; Humans; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Pyrimidines; Structure-Activity Relationship

2016